SITC’s Annual Meeting brings together researchers, clinicians, and industry leaders to advance the science of cancer immunotherapy. The meeting features cutting-edge research, oral and poster presentations, education, and discussion focused on translating immuno-oncology discoveries into better patient care.

START’s Presence: Meet with START at SITC 2026 to discuss our early-phase oncology expertise and how our dedicated investigator and site network can support the development of innovative immuno-oncology therapies.